Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

J. Richard Thistlethwaite

TitleEmeritus/Emerita, Professor
InstitutionUniversity of Chicago
DepartmentSurgery-Transplant
AddressChicago IL 60637
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Ross LF, Thistlethwaite JR. Living Donation by Individuals with Life-Limiting Conditions. J Law Med Ethics. 2019 Mar; 47(1):112-122. PMID: 30994079.
      View in: PubMed
    2. Ross LF, Thistlethwaite JR. Developing an ethics framework for living donor transplantation. J Med Ethics. 2018 12; 44(12):843-850. PMID: 29973389.
      View in: PubMed
    3. Schenck D, Mazariegos GV, Thistlethwaite JR, Ross LF. Ethical Analysis and Policy Recommendations Regarding Domino Liver Transplantation. Transplantation. 2018 05; 102(5):803-808. PMID: 29708521.
      View in: PubMed
    4. Parker WF, Thistlethwaite JR, Ross LF. Kidney Donor Profile Index Does Not Accurately Predict the Graft Survival of Pediatric Deceased Donor Kidneys. Transplantation. 2016 Nov; 100(11):2471-2478. PMID: 26760565.
      View in: PubMed
    5. Grubbs A, Meadow J, Thistlethwaite JR, Ross LF. Attitudes of Lay Stakeholders and Transplant Professionals About Disclosure to Living Kidney Donors in Exchanges and Chains. Prog Transplant. 2016 Dec; 26(4):299-308. PMID: 27571852.
      View in: PubMed
    6. Tekin Z, Garfinkel MR, Chon WJ, Schenck L, Golab K, Savari O, Thistlethwaite JR, Philipson LH, Majewski C, Pannain S, Ramachandran S, Rezania K, Hariprasad SM, Millis JM, Witkowski P. Outcomes of Pancreatic Islet Allotransplantation Using the Edmonton Protocol at the University of Chicago. Transplant Direct. 2016 Oct; 2(10):e105. PMID: 27795987.
      View in: PubMed
    7. Ross LF, Thistlethwaite JR. Introducing Genetic Tests With Uncertain Implications in Living Donor Kidney Transplantation: ApoL1 as a Case Study. Prog Transplant. 2016 Sep; 26(3):203-6. PMID: 27302054.
      View in: PubMed
    8. Ross LF, Thistlethwaite JR. The 1966 Ciba Symposium on Transplantation Ethics: 50 Years Later. Transplantation. 2016 Jun; 100(6):1191-7. PMID: 27023393.
      View in: PubMed
    9. Meadow J, Thistlethwaite JR, Rodrigue JR, Mandelbrot DA, Ross LF. To tell or not to tell: attitudes of transplant surgeons and transplant nephrologists regarding the disclosure of recipient information to living kidney donors. Clin Transplant. 2015 Dec; 29(12):1203-12. PMID: 26458148.
      View in: PubMed
    10. Cucchetti A, Ross LF, Thistlethwaite JR, Vitale A, Ravaioli M, Cescon M, Ercolani G, Burra P, Cillo U, Pinna AD. Age and equity in liver transplantation: An organ allocation model. Liver Transpl. 2015 Oct; 21(10):1241-9. PMID: 26174971.
      View in: PubMed
    11. Mataya L, Meadow J, Thistlethwaite JR, Mandelbrot DA, Rodrigue JR, Ross LF. Disclosing Health and Health Behavior Information between Living Donors and Their Recipients. Clin J Am Soc Nephrol. 2015 Sep 04; 10(9):1609-16. PMID: 26272355.
      View in: PubMed
    12. Thistlethwaite J. Patient portals: furthering the reality of patient partnership. Aust Fam Physician. 2015 Jul; 44(7):524-5. PMID: 26590502.
      View in: PubMed
    13. Saunders MR, Lee H, Alexander GC, Tak HJ, Thistlethwaite JR, Ross LF. Racial disparities in reaching the renal transplant waitlist: is geography as important as race? Clin Transplant. 2015 Jun; 29(6):531-8. PMID: 25818547.
      View in: PubMed
    14. Patel S, Ngunjiri A, Hee SW, Yang Y, Brown S, Friede T, Griffiths F, Lord J, Sandhu H, Thistlethwaite J, Tysall C, Underwood M. Primum non nocere: shared informed decision making in low back pain--a pilot cluster randomised trial. BMC Musculoskelet Disord. 2014 Aug 21; 15:282. PMID: 25146587.
      View in: PubMed
    15. Ross LF, Thistlethwaite JR. Outcomes after kidney donation. JAMA. 2014 Jul 02; 312(1):94. PMID: 25058227.
      View in: PubMed
    16. Mataya L, Aronsohn A, Thistlethwaite JR, Friedman Ross L. Decision making in liver transplantation--limited application of the liver donor risk index. Liver Transpl. 2014 Jul; 20(7):831-7. PMID: 24692309.
      View in: PubMed
    17. Chon WJ, Josephson MA, Gordon EJ, Becker YT, Witkowski P, Arwindekar DJ, Naik A, Thistlethwaite JR, Liao C, Ross LF. When the living and the deceased cannot agree on organ donation: a survey of US organ procurement organizations (OPOs). Am J Transplant. 2014 Jan; 14(1):172-7. PMID: 24369025.
      View in: PubMed
    18. Thistlethwaite JE, Bartle E, Chong AA, Dick ML, King D, Mahoney S, Papinczak T, Tucker G. A review of longitudinal community and hospital placements in medical education: BEME Guide No. 26. Med Teach. 2013 Aug; 35(8):e1340-64. PMID: 23848374.
      View in: PubMed
    19. Lowsky DJ, Ding Y, Lee DK, McCulloch CE, Ross LF, Thistlethwaite JR, Zenios SA. A K-nearest neighbors survival probability prediction method. Stat Med. 2013 May 30; 32(12):2062-9. PMID: 23653217.
      View in: PubMed
    20. Ross LF, Thistlethwaite JR. Age should not be considered in the allocation of deceased donor kidneys. Semin Dial. 2012 Nov-Dec; 25(6):675-81. PMID: 23078079.
      View in: PubMed
    21. Ross LF, Parker W, Veatch RM, Gentry SE, Thistlethwaite JR. Equal Opportunity Supplemented by Fair Innings: equity and efficiency in allocating deceased donor kidneys. Am J Transplant. 2012 Aug; 12(8):2115-24. PMID: 22703559.
      View in: PubMed
    22. Ross LF, Glannon W, Gottlieb LJ, Thistlethwaite JR. Different standards are not double standards: all elective surgical patients are not alike. J Clin Ethics. 2012; 23(2):118-28. PMID: 22822699.
      View in: PubMed
    23. Thistlethwaite J, Barr H, Gilbert J. Transforming health professionals' education. Lancet. 2011 Apr 09; 377(9773):1236; author reply 1238-9. PMID: 21481699.
      View in: PubMed
    24. Hippen BE, Thistlethwaite JR, Ross LF. Risk, prognosis, and unintended consequences in kidney allocation. N Engl J Med. 2011 Apr 07; 364(14):1285-7. PMID: 21410392.
      View in: PubMed
    25. Patel S, Brown S, Friede T, Griffiths F, Lord J, Ngunjiri A, Thistlethwaite J, Tysall C, Woolvine M, Underwood M. Study protocol: improving patient choice in treating low back pain (IMPACT-LBP): a randomised controlled trial of a decision support package for use in physical therapy. BMC Musculoskelet Disord. 2011 Feb 25; 12:52. PMID: 21352528.
      View in: PubMed
    26. Bateman J, Francis R, Thistlethwaite J. Medical student burnout and professionalism. JAMA. 2011 Jan 05; 305(1):37-8; author reply 38. PMID: 21205960.
      View in: PubMed
    27. Ajjawi R, Thistlethwaite JE, Aslani P, Cooling NB. What are the perceived learning needs of Australian general practice registrars for quality prescribing? BMC Med Educ. 2010 Dec 09; 10:92. PMID: 21143939.
      View in: PubMed
    28. Chon WJ, Kadambi PV, Harland RC, Thistlethwaite JR, West BL, Udani S, Poduval R, Josephson MA. Changing attitudes toward influenza vaccination in U.S. Kidney transplant programs over the past decade. Clin J Am Soc Nephrol. 2010 Sep; 5(9):1637-41. PMID: 20595695.
      View in: PubMed
    29. Aronsohn A, Thistlethwaite JR, Segev DL, Ross LF. How different conceptions of risk are used in the organ market debate. Am J Transplant. 2010 Apr; 10(4):931-7. PMID: 20199503.
      View in: PubMed
    30. Ross LF, Thistlethwaite JR. Long-term consequences of kidney donation. N Engl J Med. 2009 May 28; 360(22):2371; author reply 2372. PMID: 19484821.
      View in: PubMed
    31. Ross LF, Thistlethwaite JR. Minors as living solid-organ donors. Pediatrics. 2008 Aug; 122(2):454-61. PMID: 18676567.
      View in: PubMed
    32. Stewart RA, Thistlethwaite J, Evans R. Pelvic examination of asymptomatic women - attitudes and clinical practice. Aust Fam Physician. 2008 Jun; 37(6):493-6. PMID: 18523709.
      View in: PubMed
    33. Joseph JW, Thistlethwaite JR, Josephson MA, Ross LF. An empirical investigation of physicians' attitudes toward intrasibling kidney donation by minor twins. Transplantation. 2008 May 15; 85(9):1235-9. PMID: 18475177.
      View in: PubMed
    34. Ross LF, Thistlethwaite JR. Potential inefficiency of a proposed efficiency model for kidney allocation. Am J Kidney Dis. 2008 Apr; 51(4):545-8. PMID: 18371529.
      View in: PubMed
    35. Ross LF, Siegler M, Thistlethwaite JR. We need a registry of living kidney donors. Hastings Cent Rep. 2007 Nov-Dec; 37(6):1 p following 48. PMID: 18179104.
      View in: PubMed
    36. Thistlethwaite J, Heal C, Tie RN, Evans R. Shared decision making between registrars and patients--web based decision aids. Aust Fam Physician. 2007 Aug; 36(8):670-2. PMID: 17676195.
      View in: PubMed
    37. Ross LF, Zenios S, Thistlethwaite JR. Shared decision making in deceased-donor transplantation. Lancet. 2006 Jul 22; 368(9532):333-7. PMID: 16860703.
      View in: PubMed
    38. Thistlethwaite J, Evans R, Tie RN, Heal C. Shared decision making and decision aids - a literature review. Aust Fam Physician. 2006 Jul; 35(7):537-40. PMID: 16820831.
      View in: PubMed
    39. Losanoff JE, Harland RC, Thistlethwaite JR, Garfinkel MR, Williams JW, Milner J, Millis JM. Omega jejunoduodenal anastomosis for pancreas transplant. J Am Coll Surg. 2006 Jun; 202(6):1021-4. PMID: 16735221.
      View in: PubMed
    40. Ackerman PD, Thistlethwaite JR, Ross LF. Attitudes of minority patients with end-stage renal disease regarding ABO-incompatible list-paired exchanges. Am J Transplant. 2006 Jan; 6(1):83-8. PMID: 16433760.
      View in: PubMed
    41. Thistlethwaite JE. Full engagement in health: shared decision making requires education. BMJ. 2005 Jan 29; 330(7485):255. PMID: 15677675.
      View in: PubMed
    42. Poduval RD, Kadambi PV, Josephson MA, Cohn RA, Harland RC, Javaid B, Huo D, Manaligod JR, Thistlethwaite JR, Meehan SM. Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection. Transplantation. 2005 Jan 27; 79(2):228-35. PMID: 15665772.
      View in: PubMed
    43. Josephson MA, Schumm LP, Chiu MY, Marshall C, Thistlethwaite JR, Sprague SM. Calcium and calcitriol prophylaxis attenuates posttransplant bone loss. Transplantation. 2004 Oct 27; 78(8):1233-6. PMID: 15502727.
      View in: PubMed
    44. Thistlethwaite JE, Raynor DK, Knapp P. Medical students' attitudes towards concordance in medicine taking: exploring the impact of an educational intervention. Educ Health (Abingdon). 2003 Nov; 16(3):307-17. PMID: 14741879.
      View in: PubMed
    45. Meehan SM, Limsrichamrern S, Manaligod JR, Junsanto T, Josephson MA, Thistlethwaite JR, Haas M. Platelets and capillary injury in acute humoral rejection of renal allografts. Hum Pathol. 2003 Jun; 34(6):533-40. PMID: 12827606.
      View in: PubMed
    46. Ross LF, Glannon W, Josephson MA, Thistlethwaite JR. Should all living donors be treated equally? Transplantation. 2002 Aug 15; 74(3):418-21; discussion 421-2. PMID: 12177627.
      View in: PubMed
    47. Poduval RD, Meehan SM, Woodle ES, Thistlethwaite JR, Haas M, Cronin DC, Vats A, Josephson MA. Successful retransplantation after renal allograft loss to polyoma virus interstitial nephritis. Transplantation. 2002 Apr 15; 73(7):1166-9. PMID: 11965053.
      View in: PubMed
    48. Thistlethwaite JE. Making and sharing decisions about management with patients: the views and experiences of pre-registration house officers in general practice and hospital. Med Educ. 2002 Jan; 36(1):49-55. PMID: 11849524.
      View in: PubMed
    49. Fisher JS, Woodle ES, Thistlethwaite JR. Kidney transplantation: graft monitoring and immunosuppression. World J Surg. 2002 Feb; 26(2):185-93. PMID: 11865349.
      View in: PubMed
    50. Guo Z, Wang J, Meng L, Wu Q, Kim O, Hart J, He G, Zhou P, Thistlethwaite JR, Alegre ML, Fu YX, Newell KA. Cutting edge: membrane lymphotoxin regulates CD8(+) T cell-mediated intestinal allograft rejection. J Immunol. 2001 Nov 01; 167(9):4796-800. PMID: 11673481.
      View in: PubMed
    51. Guo Z, Meng L, Kim O, Wang J, Hart J, He G, Alegre ML, Thistlethwaite JR, Pearson TC, Larsen CP, Newell KA. CD8 T cell-mediated rejection of intestinal allografts is resistant to inhibition of the CD40/CD154 costimulatory pathway. Transplantation. 2001 May 15; 71(9):1351-4. PMID: 11403253.
      View in: PubMed
    52. Szot GL, Zhou P, Rulifson I, Wang J, Guo Z, Kim O, Newel KA, Thistlethwaite JR, Bluestone JA, Alegre ML. Different mechanisms of cardiac allograft rejection in wildtype and CD28-deficient mice. Am J Transplant. 2001 May; 1(1):38-46. PMID: 12095035.
      View in: PubMed
    53. Meehan SM, Domer P, Josephson M, Donoghue M, Sadhu A, Ho LT, Aronson AJ, Thistlethwaite JR, Haas M. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies. Hum Pathol. 2001 Feb; 32(2):205-15. PMID: 11230708.
      View in: PubMed
    54. Alegre M, Fallarino F, Zhou P, Frauwirth K, Thistlethwaite J, Newell K, Gajewski T, Bluestone J. Transplantation and the CD28/CTLA4/B7 pathway. Transplant Proc. 2001 Feb-Mar; 33(1-2):209-11. PMID: 11266782.
      View in: PubMed
    55. Zhou P, Szot G, Guo Z, Kim O, He G, Wang J, Grusby M, Newell K, Thistlethwaite J, Bluestone J, Alegre M. Role of STAT6 signaling in the induction and long-term maintenance of tolerance mediated by CTLA4-Ig. Transplant Proc. 2001 Feb-Mar; 33(1-2):214-6. PMID: 11266784.
      View in: PubMed
    56. Zhou P, Szot GL, Guo Z, Kim O, He G, Wang J, Grusby MJ, Newell KA, Thistlethwaite JR, Bluestone JA, Alegre ML. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance. J Immunol. 2000 Nov 15; 165(10):5580-7. PMID: 11067913.
      View in: PubMed
    57. Thistlethwaite JR, Nashan B, Hall M, Chodoff L, Lin TH. Reduced acute rejection and superior 1-year renal allograft survival with basiliximab in patients with diabetes mellitus. The Global Simulect Study Group. Transplantation. 2000 Sep 15; 70(5):784-90. PMID: 11003358.
      View in: PubMed
    58. Grewal HP, Brady L, Cronin DC, Loss GE, Siegel CT, Oswald K, Fisher JS, Bruce DS, Aronson AJ, Woodle ES, Millis JM, Thistlethwaite JR, Newell KA. Combined liver and kidney transplantation in children. Transplantation. 2000 Jul 15; 70(1):100-5. PMID: 10919582.
      View in: PubMed
    59. Millis JM, Cronin DC, Brady LM, Newell KA, Woodle ES, Bruce DS, Thistlethwaite JR, Broelsch CE. Primary living-donor liver transplantation at the University of Chicago: technical aspects of the first 104 recipients. Ann Surg. 2000 Jul; 232(1):104-11. PMID: 10862202.
      View in: PubMed
    60. Szot GL, Zhou P, Sharpe AH, He G, Kim O, Newell KA, Bluestone JA, Thistlethwaite JR. Absence of host B7 expression is sufficient for long-term murine vascularized heart allograft survival. Transplantation. 2000 Mar 15; 69(5):904-9. PMID: 10755548.
      View in: PubMed
    61. Thistlethwaite JE. Introducing community-based teaching of third year medical students: outcomes of a pilot project one year later and implications for managing change. Educ Health (Abingdon). 2000; 13(1):53-62. PMID: 14741794.
      View in: PubMed
    62. Alexander JW, Light JA, Donaldson LA, Delmonico FL, Diethelm AG, Wilkinson A, Rosenthal JT, Thistlethwaite JR, Hunsicker LG, Matas AJ, First MR, Reinsmoen NL, Rose SM. Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research Group. Transplantation. 1999 Oct 27; 68(8):1117-24. PMID: 10551639.
      View in: PubMed
    63. Woodle ES, Xu D, Zivin RA, Auger J, Charette J, O'Laughlin R, Peace D, Jollife LK, Haverty T, Bluestone JA, Thistlethwaite JR. Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection. Transplantation. 1999 Sep 15; 68(5):608-16. PMID: 10507477.
      View in: PubMed
    64. Josephson MA, Chiu MY, Woodle ES, Thistlethwaite JR, Haas M. Drug-induced acute interstitial nephritis in renal allografts: histopathologic features and clinical course in six patients. Am J Kidney Dis. 1999 Sep; 34(3):540-8. PMID: 10469866.
      View in: PubMed
    65. Newell KA, He G, Guo Z, Kim O, Szot GL, Rulifson I, Zhou P, Hart J, Thistlethwaite JR, Bluestone JA. Cutting edge: blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells. J Immunol. 1999 Sep 01; 163(5):2358-62. PMID: 10452966.
      View in: PubMed
    66. Theriault BR, Thistlethwaite JR, Levisetti MG, Wardrip CL, Szot G, Bruce DS, Rilo H, Li X, Gray GS, Bluestone JA, Padrid PA. Induction, maintenance, and reversal of streptozotocin-induced insulin-dependent diabetes mellitus in the juvenile cynomolgus monkey (Macaca fascilularis). Transplantation. 1999 Aug 15; 68(3):331-7. PMID: 10459535.
      View in: PubMed
    67. Meehan SM, Siegel CT, Aronson AJ, Bartosh SM, Thistlethwaite JR, Woodle ES, Haas M. The relationship of untreated borderline infiltrates by the Banff criteria to acute rejection in renal allograft biopsies. J Am Soc Nephrol. 1999 Aug; 10(8):1806-14. PMID: 10446950.
      View in: PubMed
    68. Haas M, Meehan SM, Josephson MA, Wit EJ, Woodle ES, Thistlethwaite JR. Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity. Am J Kidney Dis. 1999 Jul; 34(1):69-84. PMID: 10401019.
      View in: PubMed
    69. He G, Kim OS, Thistlethwaite JR, Hart J, Siegel CT, Szot GL, Newell KA. Differential effect of an anti-CD8 monoclonal antibody on rejection of murine intestine and cardiac allografts. Transplant Proc. 1999 Feb-Mar; 31(1-2):1239-41. PMID: 10083553.
      View in: PubMed
    70. He G, Hart J, Kim OS, Szot GL, Siegel CT, Thistlethwaite JR, Newell KA. The role of CD8 and CD4 T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice. Transplantation. 1999 Jan 15; 67(1):131-7. PMID: 9921809.
      View in: PubMed
    71. He G, Hart J, Thistlethwaite JR, Newell KA. Modified surgical model of paratopic small bowel transplantation in mice. J Surg Res. 1998 Dec; 80(2):188-93. PMID: 9878312.
      View in: PubMed
    72. Woodle ES, Millis JM, So SK, McDiarmid SV, Busuttil RW, Esquivel CO, Whitington PF, Thistlethwaite JR. Liver transplantation in the first three months of life. Transplantation. 1998 Sep 15; 66(5):606-9. PMID: 9753340.
      View in: PubMed
    73. He G, Hart J, Thistlethwaite JR, Newell KA. Role of CD8+ and CD4+ T cells in the rejection of murine intestinal allografts. Transplant Proc. 1998 Sep; 30(6):2592-3. PMID: 9745505.
      View in: PubMed
    74. Dachman AH, Newmark GM, Thistlethwaite JR, Oto A, Bruce DS, Newell KA. Imaging of pancreatic transplantation using portal venous and enteric exocrine drainage. AJR Am J Roentgenol. 1998 Jul; 171(1):157-63. PMID: 9648780.
      View in: PubMed
    75. Arnow PM, Zachary KC, Thistlethwaite JR, Thompson KD, Bova JL, Newell KA. Pathogenesis of early operative site infections after orthotopic liver transplantation. Transplantation. 1998 Jun 15; 65(11):1500-3. PMID: 9645812.
      View in: PubMed
    76. Turner CD, Bruce DS, Cronin DC, Loss GE, Grewal H, Siegel C, Millis JM, Newell KA, Davis B, Todo T, Thistlethwaite JR, Woodle ES. Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach. Transplant Proc. 1998 Jun; 30(4):1234-5. PMID: 9636501.
      View in: PubMed
    77. Woodle ES, Bluestone JA, Zivin RA, Jolliffe LK, Auger J, Xu D, Thistlethwaite JR. Humanized, nonmitogenic OKT3 antibody, huOKT3 gamma(Ala-Ala): initial clinical experience. Transplant Proc. 1998 Jun; 30(4):1369-70. PMID: 9636555.
      View in: PubMed
    78. Grewal HP, Thistlethwaite JR, Loss GE, Bruce DS, Siegel CT, Cronin DC, Newell KA, Millis JM, Woodle ES. Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression. Transplant Proc. 1998 Jun; 30(4):1378-9. PMID: 9636558.
      View in: PubMed
    79. Loss GE, Brady L, Grewal HP, Siegel CT, Mead J, Bruce DS, Cronin DC, Woodle ES, Newell KA, Thistlethwaite JR, Millis JM. Cyclosporine versus cyclosporine microemulsion in pediatric liver transplant recipients. Transplant Proc. 1998 Jun; 30(4):1435-6. PMID: 9636581.
      View in: PubMed
    80. Bruce DS, Woodle ES, Newell KA, Millis JM, Cronin DC, Loss GE, Grewal HP, Siegel CT, Pellar S, Josephson MA, Thistlethwaite JR. Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation. Transplant Proc. 1998 Jun; 30(4):1538-40. PMID: 9636625.
      View in: PubMed
    81. He G, Hart J, Thistlethwaite JR, Newell KA. Inhibition of intestinal allograft rejection by an anti-CD8 monoclonal antibody is not mediated by depletion alone. Transplant Proc. 1998 Jun; 30(4):1069-70. PMID: 9636433.
      View in: PubMed
    82. Millis JM, Cronin DC, Newell KA, Bruce DS, Woodle ES, Grewal HP, Loss GE, Lissoos T, Conjeevaram H, Schiano T, O'Laughlin R, Charette J, McNaughton M, Baker AL, Thistlethwaite JR. Successful use of tacrolimus for initial rejection episodes after liver transplantation. Transplant Proc. 1998 Jun; 30(4):1407-8. PMID: 9636569.
      View in: PubMed
    83. Newell KA, Millis JM, Bruce DS, Woodle ES, Cronin DC, Loss G, Grewal H, Alonso EM, Dillon JJ, Whitington PF, Thistlethwaite JR. An analysis of hepatic retransplantation in children. Transplantation. 1998 May 15; 65(9):1172-8. PMID: 9603163.
      View in: PubMed
    84. Chiu MY, Sprague SM, Bruce DS, Woodle ES, Thistlethwaite JR, Josephson MA. Analysis of fracture prevalence in kidney-pancreas allograft recipients. J Am Soc Nephrol. 1998 Apr; 9(4):677-83. PMID: 9555671.
      View in: PubMed
    85. Bruce DS, Woodle ES, Newell KA, Millis JM, Cronin DC, Loss GE, Pellar S, Josephson MA, Thistlethwaite JR. Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation. Transplant Proc. 1998 Mar; 30(2):507-8. PMID: 9532150.
      View in: PubMed
    86. Bruce DS, Newell KA, Woodle ES, Cronin DC, Grewal HP, Millis JM, Ruebe M, Josephson MA, Thistlethwaite JR. Synchronous pancreas-kidney transplantation with portal venous and enteric exocrine drainage: outcome in 70 consecutive cases. Transplant Proc. 1998 Mar; 30(2):270-1. PMID: 9532030.
      View in: PubMed
    87. Befeler AS, Lissoos TW, Schiano TD, Conjeevaram H, Dasgupta KA, Millis JM, Newell KA, Thistlethwaite JR, Baker AL. Clinical course and management of inflammatory bowel disease after liver transplantation. Transplantation. 1998 Feb 15; 65(3):393-6. PMID: 9484758.
      View in: PubMed
    88. Newell KA, Millis JM, Arnow PM, Bruce DS, Woodle ES, Cronin DC, Loss GE, Grewal H, Lissoos T, Schiano T, Mead J, Thistlethwaite JR. Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation. Transplantation. 1998 Feb 15; 65(3):439-42. PMID: 9484768.
      View in: PubMed
    89. Levisetti MG, Padrid PA, Szot GL, Mittal N, Meehan SM, Wardrip CL, Gray GS, Bruce DS, Thistlethwaite JR, Bluestone JA. Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation. J Immunol. 1997 Dec 01; 159(11):5187-91. PMID: 9548454.
      View in: PubMed
    90. Newell KA, He G, Hart J, Thistlethwaite JR. Treatment with either anti-CD4 or anti-CD8 monoclonal antibodies blocks alphabeta T cell-mediated rejection of intestinal allografts in mice. Transplantation. 1997 Oct 15; 64(7):959-65. PMID: 9381541.
      View in: PubMed
    91. Woodle ES, Newell KA, Haas M, Bartosh S, Josephson MA, Millis JM, Bruce DS, Piper JB, Aronson AJ, Thistlethwaite JR. Reversal of accelerated renal allograft rejection with FK 506. Clin Transplant. 1997 Aug; 11(4):251-4. PMID: 9267710.
      View in: PubMed
    92. Sher LS, Cosenza CA, Michel J, Makowka L, Miller CM, Schwartz ME, Busuttil R, McDiarmid S, Burdick JF, Klein AS, Esquivel C, Klintmalm G, Levy M, Roberts JP, Lake JR, Kalayoglu M, D'Alessandro AM, Gordon RD, Stieber AC, Shaw BW, Thistlethwaite JR, Whittington P, Wiesner RH, Porayko M, Cosimi AB, et al. Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: a report of the U.S. Multicenter Liver Study Group. Transplantation. 1997 Jul 27; 64(2):258-63. PMID: 9256184.
      View in: PubMed
    93. Lee MY, Finn HA, Lazda VA, Thistlethwaite JR, Simon MA. Bone allografts are immunogenic and may preclude subsequent organ transplants. Clin Orthop Relat Res. 1997 Jul; (340):215-9. PMID: 9224259.
      View in: PubMed
    94. Newell KA, Alonso EM, Kelly SM, Rubin CM, Thistlethwaite JR, Whitington PF. Association between liver transplantation for Langerhans cell histiocytosis, rejection, and development of posttransplant lymphoproliferative disease in children. J Pediatr. 1997 Jul; 131(1 Pt 1):98-104. PMID: 9255199.
      View in: PubMed
    95. Millis JM, Thistlethwaite JR. Transplantation. JAMA. 1997 Jun 18; 277(23):1902-4. PMID: 9185827.
      View in: PubMed
    96. Ross LF, Rubin DT, Siegler M, Josephson MA, Thistlethwaite JR, Woodle ES. Ethics of a paired-kidney-exchange program. N Engl J Med. 1997 Jun 12; 336(24):1752-5. PMID: 9180096.
      View in: PubMed
    97. Millis JM, Cronin DC, Newell KA, Piper JB, Woodle ES, Bruce DS, Conjeevaram H, Baker AL, Thistlethwaite JR. Tacrolimus treatment of steroid-resistant rejection provides economic advantages compared with OKT3 therapy. Transplant Proc. 1997 Feb-Mar; 29(1-2):1549. PMID: 9123421.
      View in: PubMed
    98. Millis JM, Cronin DC, Piper JB, Newell KA, Bruce DS, Woodle ES, Davis B, Seaman E, Thistlethwaite JR. Impact of a liberalized donor acceptance policy on liver transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):484. PMID: 9123094.
      View in: PubMed
    99. Newell KA, Alonso EM, Millis JM, Piper JB, Bruce DS, Woodle ES, Cronin DC, Whitington PF, Thistlethwaite JR. Retransplantation for failed hepatic allografts in children. Transplant Proc. 1997 Feb-Mar; 29(1-2):442-3. PMID: 9123072.
      View in: PubMed
    100. Cronin DC, Alonso EM, Piper JB, Newell KA, Bruce DS, Woodle ES, Whitington PF, Thistlethwaite JR, Millis JM. Biliary complications in living donor liver transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):419-20. PMID: 9123062.
      View in: PubMed
    101. Cronin DC, Bruce DS, Newell KA, Josephson MA, Millis JM, Piper JB, Ruebe M, Kirby M, Thistlethwaite JR, Woodle ES. Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal. Transplant Proc. 1997 Feb-Mar; 29(1-2):307. PMID: 9123010.
      View in: PubMed
    102. Woodle ES, Thistlethwaite JR, Gordon JH. Tacrolimus therapy for refractory acute renal allograft rejection: a prospective multicenter trial. Tacrolimus Kidney Transplantation Rescue Study Group. Transplant Proc. 1996 Dec; 28(6):3163-4. PMID: 8962225.
      View in: PubMed
    103. Whitington PF, Rubin CM, Alonso EM, McKeithan TW, Anastasi J, Hart J, Thistlethwaite JR. Complete lymphoid chimerism and chronic graft-versus-host disease in an infant recipient of a hepatic allograft from an HLA-homozygous parental living donor. Transplantation. 1996 Nov 27; 62(10):1516-9. PMID: 8958284.
      View in: PubMed
    104. Newell KA, Bruce DS, Cronin DC, Woodle ES, Millis JM, Piper JB, Huss E, Thistlethwaite JR. Comparison of pancreas transplantation with portal venous and enteric exocrine drainage to the standard technique utilizing bladder drainage of exocrine secretions. Transplantation. 1996 Nov 15; 62(9):1353-6. PMID: 8932284.
      View in: PubMed
    105. Seaman DS, Newell KA, Piper JB, Bruce DS, Woodle ES, Cronin DC, Alonso EM, Whitington PF, Thistlethwaite JR, Millis JM. Use of polytetrafluoroethylene patch for temporary wound closure after pediatric liver transplantation. Transplantation. 1996 Oct 15; 62(7):1034-6. PMID: 8878403.
      View in: PubMed
    106. Woodle ES, Cronin D, Newell KA, Millis JM, Bruce DS, Piper JB, Haas M, Josephson MA, Thistlethwaite JR. Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies. Transplantation. 1996 Oct 15; 62(7):906-10. PMID: 8878382.
      View in: PubMed
    107. Millis JM, Seaman DS, Piper JB, Alonso EM, Kelly S, Hackworth CA, Newell KA, Bruce DS, Woodle ES, Thistlethwaite JR, Whitington PF. Portal vein thrombosis and stenosis in pediatric liver transplantation. Transplantation. 1996 Sep 27; 62(6):748-54. PMID: 8824471.
      View in: PubMed
    108. Woodle ES, Thistlethwaite JR, Gordon JH, Laskow D, Deierhoi MH, Burdick J, Pirsch JD, Sollinger H, Vincenti F, Burrows L, Schwartz B, Danovitch GM, Wilkinson AH, Shaffer D, Simpson MA, Freeman RB, Rohrer RJ, Mendez R, Aswad S, Munn SR, Wiesner RH, Delmonico FL, Neylan J, Whelchel J. A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group. Transplantation. 1996 Sep 15; 62(5):594-9. PMID: 8830821.
      View in: PubMed
    109. Bruce DS, Newell KA, Josephson MA, Woodle ES, Piper JB, Millis JM, Seaman DS, Carnrike CL, Huss E, Thistlethwaite JR. Long-term outcome of kidney-pancreas transplant recipients with good graft function at one year. Transplantation. 1996 Aug 27; 62(4):451-6. PMID: 8781609.
      View in: PubMed
    110. Newell KA, Alonso EM, Whitington PF, Bruce DS, Millis JM, Piper JB, Woodle ES, Kelly SM, Koeppen H, Hart J, Rubin CM, Thistlethwaite JR. Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression. Transplantation. 1996 Aug 15; 62(3):370-5. PMID: 8779685.
      View in: PubMed
    111. Bruce DS, Newell KA, Woodle ES, Millis JM, Piper JB, Huss E, Thistlethwaite JR. Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation. Transplant Proc. 1996 Aug; 28(4):2136-7. PMID: 8769180.
      View in: PubMed
    112. Woodle ES, Bruce DS, Josephson M, Cronin D, Newell KA, Millis JM, Piper JB, O'Laughlin R, Thistlethwaite JR. OKT3 escalating dose regimens provide effective therapy for renal allograft rejection. Clin Transplant. 1996 Aug; 10(4):389-95. PMID: 8884115.
      View in: PubMed
    113. Woodle ES, Bruce DS, Josephson M, Newell KA, Piper JB, Millis JM, Cronin D, Whitman G, Ruebe M, Thistlethwaite JR. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Clin Transplant. 1996 Aug; 10(4):323-32. PMID: 8884103.
      View in: PubMed
    114. Millis JM, Woodle ES, Piper JB, Bruce DS, Newell KA, Seaman DS, Baker AL, Hart J, Dasgupta K, Thistlethwaite JR. Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection. Transplantation. 1996 May 15; 61(9):1365-9. PMID: 8629298.
      View in: PubMed
    115. Kostelic JK, Piper JB, Leef JA, Lu CT, Rosenblum JD, Hackworth C, Kahn J, Thistlethwaite JR, Whitington PF. Angiographic selection criteria for living related liver transplant donors. AJR Am J Roentgenol. 1996 May; 166(5):1103-8. PMID: 8615252.
      View in: PubMed
    116. Millis JM, Bruce DS, Newell KA, Piper JB, Woodle ES, Seaman DS, Baker AL, Hart J, Dasgupta K, Thistlethwaite JR. Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients. Transplant Proc. 1996 Apr; 28(2):1014. PMID: 8623213.
      View in: PubMed
    117. Woodle ES, Thistlethwaite JR, Haas M, Josephson MA, Newell KA, Bruce DS, Millis JM, Piper JB, Charette JI. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506. Transplant Proc. 1996 Apr; 28(2):998-9. PMID: 8623495.
      View in: PubMed
    118. Abramowicz D, Norman DJ, Vereerstraeten P, Goldman M, De Pauw L, Vanherweghem JL, Kinnaert P, Kahana L, Stuart FP, Thistlethwaite JR, Shield CF, Monaco A, Wu SC, Haverty TP. OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: association with improvement in long-term survival. Kidney Int. 1996 Mar; 49(3):768-72. PMID: 8648918.
      View in: PubMed
    119. Alonso EM, Piper JB, Echols G, Thistlethwaite JR, Whitington PF. Allograft rejection in pediatric recipients of living related liver transplants. Hepatology. 1996 Jan; 23(1):40-3. PMID: 8550046.
      View in: PubMed
    120. Newell KA, Woodle ES, Millis JM, Piper JB, Huss E, Seaman DS, Bruce DS, Thistlethwaite JR. Pancreas transplantation with portal venous drainage and enteric exocrine drainage offers early advantages without compromising safety or allograft function. Transplant Proc. 1995 Dec; 27(6):3002-3. PMID: 8539812.
      View in: PubMed
    121. Bruce DS, Newell KA, Woodle ES, Millis JM, Piper JB, Seaman DS, Huss E, Thistlethwaite JR. Late complications in kidney-pancreas transplant recipients. Transplant Proc. 1995 Dec; 27(6):3118. PMID: 8539871.
      View in: PubMed
    122. Lenschow DJ, Zeng Y, Hathcock KS, Zuckerman LA, Freeman G, Thistlethwaite JR, Gray GS, Hodes RJ, Bluestone JA. Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies. Transplantation. 1995 Nov 27; 60(10):1171-8. PMID: 7482727.
      View in: PubMed
    123. Hibberd PL, Tolkoff-Rubin NE, Conti D, Stuart F, Thistlethwaite JR, Neylan JF, Snydman DR, Freeman R, Lorber MI, Rubin RH. Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial. Ann Intern Med. 1995 Jul 01; 123(1):18-26. PMID: 7762909.
      View in: PubMed
    124. Zeng Y, Torres M, Wang Y, Montag A, Thistlethwaite JR. Intrathymic xenogeneic pancreatic islet transplantation--induction of donor-specific unresponsiveness by MHC class II peptides. Transplant Proc. 1995 Feb; 27(1):176-7. PMID: 7878961.
      View in: PubMed
    125. Smith DM, Bluestone JA, Thistlethwaite JR, Woodle ES. Inhibition of T-cell activation by an anti-human class I MHC reactive monoclonal antibody occurs at a point distal to TCR-CD3 mediated signal transduction. Transplant Proc. 1995 Feb; 27(1):395-7. PMID: 7879035.
      View in: PubMed
    126. Zeng Y, Peterson L, Levisetti M, Torres M, Montag A, Thistlethwaite JR. Immunomodulation of human islets results in prolonged in vivo islet graft survival. Transplant Proc. 1995 Feb; 27(1):611-2. PMID: 7879118.
      View in: PubMed
    127. Abramowicz D, Norman DJ, Goldman M, De Pauw L, Kinnaert P, Kahana L, Thistlethwaite JR, Shield CF, Monaco AP, Vanherweghem JL, et al. OKT3 prophylaxis improves long-term renal graft survival in high-risk patients as compared to cyclosporine: combined results from the prospective, randomized Belgian and US studies. Transplant Proc. 1995 Feb; 27(1):852-3. PMID: 7879204.
      View in: PubMed
    128. Jeyarajah DR, Kadakia RA, O'Toole K, Newell KA, Josephson MA, Spargo BH, Woodle ES, Thistlethwaite JR. Changes in urinary cytokine mRNA profile after successful therapy for acute cellular renal allograft rejection. Transplant Proc. 1995 Feb; 27(1):887-9. PMID: 7879220.
      View in: PubMed
    129. Millis JM, Alonso EM, Piper JB, Bruce DS, Newell KA, Woodle ES, Baker AL, Whitington PF, Thistlethwaite JR. Liver transplantation at the University of Chicago. Clin Transpl. 1995; 187-97. PMID: 8794265.
      View in: PubMed
    130. Josephson MA, Spargo B, Hollandsworth D, Thistlethwaite JR. The recurrence of recurrent membranous glomerulopathy in a renal transplant recipient: case report and literature review. Am J Kidney Dis. 1994 Nov; 24(5):873-8. PMID: 7977333.
      View in: PubMed
    131. Zeng Y, Gage A, Montag A, Rothlein R, Thistlethwaite JR, Bluestone JA. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies. Transplantation. 1994 Sep 27; 58(6):681-9. PMID: 7940687.
      View in: PubMed
    132. Alegre ML, Peterson LJ, Jeyarajah DR, Weiser M, Bluestone JA, Thistlethwaite JR. Severe combined immunodeficient mice engrafted with human splenocytes have functional human T cells and reject human allografts. J Immunol. 1994 Sep 15; 153(6):2738-49. PMID: 8077678.
      View in: PubMed
    133. Smith DM, Bluestone JA, Jeyarajah DR, Newberg MH, Engelhard VH, Thistlethwaite JR, Woodle ES. Inhibition of T cell activation by a monoclonal antibody reactive against the alpha 3 domain of human MHC class I molecules. J Immunol. 1994 Aug 01; 153(3):1054-67. PMID: 7913109.
      View in: PubMed
    134. Alegre ML, Peterson LJ, Xu D, Sattar HA, Jeyarajah DR, Kowalkowski K, Thistlethwaite JR, Zivin RA, Jolliffe L, Bluestone JA. A non-activating "humanized" anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo. Transplantation. 1994 Jun 15; 57(11):1537-43. PMID: 8009586.
      View in: PubMed
    135. Jeyarajah DR, Schmeisser FS, Kadakia RA, Thistlethwaite JR. Prolongation of skin xenograft survival with concomitant donor bone marrow transplantation. Transplant Proc. 1994 Jun; 26(3):1201-2. PMID: 8029886.
      View in: PubMed
    136. Zeng Y, Torres MA, Thistlethwaite JR, Montag A, Bluestone JA. Prolongation of human pancreatic islet xenografts by pretreatment of islets with anti-human ICAM-1 monoclonal antibody. Transplant Proc. 1994 Jun; 26(3):1120. PMID: 7913254.
      View in: PubMed
    137. Jeyarajah DR, Schmeisser FS, Josephson MA, Sohn DG, Thistlethwaite JR. Low-dose anti-CD3 therapy provides long-term graft survival in a Lewis rat to C57BL/6 xeno-islet transplantation model. Transplant Proc. 1994 Apr; 26(2):771-3. PMID: 8171656.
      View in: PubMed
    138. Zeng Y, Torre MA, Karrison T, Thistlethwaite JR. The correlation between donor characteristics and the success of human islet isolation. Transplantation. 1994 Mar 27; 57(6):954-8. PMID: 7512294.
      View in: PubMed
    139. Piper JB, Whitington PF, Woodle ES, Newell KA, Alonso EM, Thistlethwaite JR. Living related liver transplantation in children: a report of the first 58 recipients at the University of Chicago. Transpl Int. 1994; 7 Suppl 1:S111-3. PMID: 11271179.
      View in: PubMed
    140. Whitington PF, Emond JC, Heffron T, Thistlethwaite JR. Orthotopic auxiliary liver transplantation for Crigler-Najjar syndrome type 1. Lancet. 1993 Sep 25; 342(8874):779-80. PMID: 7690444.
      View in: PubMed
    141. O'Meara NM, Sturis J, Blackman JD, Byrne MM, Jaspan JB, Roland DC, Thistlethwaite JR, Polonsky KS. Oscillatory insulin secretion after pancreas transplant. Diabetes. 1993 Jun; 42(6):855-61. PMID: 8495809.
      View in: PubMed
    142. Jeyarajah DR, Thistlethwaite JR. General aspects of cytokine-release syndrome: timing and incidence of symptoms. Transplant Proc. 1993 Apr; 25(2 Suppl 1):16-20. PMID: 8465415.
      View in: PubMed
    143. Bluestone JA, Bruce D, Peterson L, Thistlethwaite JR, Josephson M, Zeng Y, Linsley PS, Lenschow DJ. Immunosuppressive effects of anti-CD3 MAb and soluble co-stimulatory molecules. Transplant Proc. 1993 Feb; 25(1 Pt 1):546-7. PMID: 8438407.
      View in: PubMed
    144. Heffron TG, Kortz EO, Contis JC, Watkins CW, Davis B, Jasionowski T, Thistlethwaite JR, Karp RB, Emond JC. Use of cryopreserved vein allogeneic homografts in liver transplantation. Transplant Proc. 1993 Feb; 25(1 Pt 2):1091-2. PMID: 8442053.
      View in: PubMed
    145. Bartosh SM, Aronson AJ, Swanson-Pewitt EE, Thistlethwaite JR. OKT3 induction in pediatric renal transplantation. Pediatr Nephrol. 1993 Feb; 7(1):45-9. PMID: 8382505.
      View in: PubMed
    146. Norman DJ, Kahana L, Stuart FP, Thistlethwaite JR, Shield CF, Monaco A, Dehlinger J, Wu SC, Van Horn A, Haverty TP. A randomized clinical trial of induction therapy with OKT3 in kidney transplantation. Transplantation. 1993 Jan; 55(1):44-50. PMID: 8420063.
      View in: PubMed
    147. Vedantham S, Taylor FC, Yousefzadeh DK, Udekwu P, Thistlethwaite JR, Whitington PF. Abdominal pain in a young girl due to congenital stenosis of the common bile duct with mucus plug formation. J Pediatr Gastroenterol Nutr. 1992 Nov; 15(4):440-3. PMID: 1469527.
      View in: PubMed
    148. Blackman JD, Polonsky KS, Jaspan JB, Sturis J, Van Cauter E, Thistlethwaite JR. Insulin secretory profiles and C-peptide clearance kinetics at 6 months and 2 years after kidney-pancreas transplantation. Diabetes. 1992 Oct; 41(10):1346-54. PMID: 1397710.
      View in: PubMed
    149. Lenschow DJ, Zeng Y, Thistlethwaite JR, Montag A, Brady W, Gibson MG, Linsley PS, Bluestone JA. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science. 1992 Aug 07; 257(5071):789-92. PMID: 1323143.
      View in: PubMed
    150. George DL, Arnow PM, Fox A, Thistlethwaite JR, Emond JC, Broelsch CE, Whitington PF. Patterns of infection after pediatric liver transplantation. Am J Dis Child. 1992 Aug; 146(8):924-9. PMID: 1636658.
      View in: PubMed
    151. Alegre ML, Collins AM, Pulito VL, Brosius RA, Olson WC, Zivin RA, Knowles R, Thistlethwaite JR, Jolliffe LK, Bluestone JA. Effect of a single amino acid mutation on the activating and immunosuppressive properties of a "humanized" OKT3 monoclonal antibody. J Immunol. 1992 Jun 01; 148(11):3461-8. PMID: 1534096.
      View in: PubMed
    152. Woodle ES, Thistlethwaite JR, Jolliffe LK, Zivin RA, Collins A, Adair JR, Bodmer M, Athwal D, Alegre ML, Bluestone JA. Humanized OKT3 antibodies: successful transfer of immune modulating properties and idiotype expression. J Immunol. 1992 May 01; 148(9):2756-63. PMID: 1533410.
      View in: PubMed
    153. Josephson MA, Schmeisser S, Sohn D, Buckingham F, Thistlethwaite JR. Rat to mouse pancreas xenografts: comparison to islet xenografts. Transplant Proc. 1992 Apr; 24(2):653-4. PMID: 1566467.
      View in: PubMed
    154. Heffron TG, Emond JC, Whitington PF, Thistlethwaite JR, Stevens L, Piper J, Whitington S, Broelsch CE. Biliary complications in pediatric liver transplantation. A comparison of reduced-size and whole grafts. Transplantation. 1992 Feb; 53(2):391-5. PMID: 1738934.
      View in: PubMed
    155. Stevens LH, Emond JC, Piper JB, Heffron TG, Thistlethwaite JR, Whitington PF, Broelsch CE. Hepatic artery thrombosis in infants. A comparison of whole livers, reduced-size grafts, and grafts from living-related donors. Transplantation. 1992 Feb; 53(2):396-9. PMID: 1738935.
      View in: PubMed
    156. Piper JB, Whitington PF, Woodle ES, Newell KA, Alonso EM, Emond JC, Heffron TG, Broelsch CE, Thistlethwaite JR. Pediatric liver transplantation at the University of Chicago Hospitals. Clin Transpl. 1992; 179-89. PMID: 1306696.
      View in: PubMed
    157. Broelsch CE, Whitington PF, Emond JC, Heffron TG, Thistlethwaite JR, Stevens L, Piper J, Whitington SH, Lichtor JL. Liver transplantation in children from living related donors. Surgical techniques and results. Ann Surg. 1991 Oct; 214(4):428-37; discussion 437-9. PMID: 1953097.
      View in: PubMed
    158. Woodle ES, Thistlethwaite JR, Ghobrial IA, Jolliffe LK, Stuart FP, Bluestone JA. OKT3 F(ab')2 fragments--retention of the immunosuppressive properties of whole antibody with marked reduction in T cell activation and lymphokine release. Transplantation. 1991 Aug; 52(2):354-60. PMID: 1908148.
      View in: PubMed
    159. Woodle ES, Thistlethwaite JR, Jolliffe LK, Fucello AJ, Stuart FP, Bluestone JA. Anti-CD3 monoclonal antibody therapy. An approach toward optimization by in vitro analysis of new anti-CD3 antibodies. Transplantation. 1991 Aug; 52(2):361-8. PMID: 1714644.
      View in: PubMed
    160. Thistlethwaite JR, Emond JC, Heffron TG, Whitington PF, Black DD, Broelsch CE. Innovative use of organs for liver transplantation. Transplant Proc. 1991 Aug; 23(4):2147-51. PMID: 1871833.
      View in: PubMed
    161. Vogelbach P, Emond JC, Thistlethwaite JR, Broelsch CE. [Splitting liver transplantation. Orthotopic liver transplantation in two recipients with a single donor liver]. Helv Chir Acta. 1991 Jul; 58(1-2):147-8. PMID: 1938435.
      View in: PubMed
    162. Vogelbach P, Emond JC, Thistlethwaite JR, Broelsch CE. [Preservation of donor livers with University of Wisconsin solution]. Helv Chir Acta. 1991 Jul; 58(1-2):159-61. PMID: 1938437.
      View in: PubMed
    163. Woodle ES, Thistlethwaite JR, Emond JC, Whitington PF, Black DD, Aran PP, Baker AL, Stuart FP, Broelsch CE. OKT3 therapy for hepatic allograft rejection. Differential response in adults and children. Transplantation. 1991 Jun; 51(6):1207-12. PMID: 1904662.
      View in: PubMed
    164. George DL, Arnow PM, Fox AS, Baker AL, Thistlethwaite JR, Emond JC, Whitington PF, Broelsch CE. Bacterial infection as a complication of liver transplantation: epidemiology and risk factors. Rev Infect Dis. 1991 May-Jun; 13(3):387-96. PMID: 1866541.
      View in: PubMed
    165. Whitington PF, Emond JC, Black DD, Whitington SH, Boone P, Smith C, Thistlethwaite JR, Broelsch CE. Indications for liver transplantation in pediatric patients. Clin Transplant. 1991 Apr; 5(2 part 2):155-60. PMID: 10147638.
      View in: PubMed
    166. Woodle ES, Thistlethwaite JR, Jolliffe LK, Ghobrial I, Fuccello AJ, Stuart FP, Bluestone JA. T-cell activation and lymphokine production induced by antihuman CD3 monoclonal antibodies. Transplant Proc. 1991 Feb; 23(1 Pt 1):81-2. PMID: 1824999.
      View in: PubMed
    167. Heimann P, Josephson MA, Fellner SK, Thistlethwaite JR, Stuart FP, Dasgupta A. Elevated lipoprotein(a) levels in renal transplantation and hemodialysis patients. Am J Nephrol. 1991; 11(6):470-4. PMID: 1840233.
      View in: PubMed
    168. Heffron TG, Gadowski G, Buckingham F, Salciunas P, Thistlethwaite JR, Stuart FP. Laser Doppler blood flow measurement as a predictor of viability of renal allografts. Curr Surg. 1990 Nov-Dec; 47(6):431-2. PMID: 2279400.
      View in: PubMed
    169. Ellenhorn JD, Woodle ES, Thistlethwaite JR, Bluestone JA. T lymphocyte activation following OKT3 treatment. Curr Surg. 1990 Nov-Dec; 47(6):458-9. PMID: 2279409.
      View in: PubMed
    170. Ellenhorn JD, Woodle ES, Ghobreal I, Thistlethwaite JR, Bluestone JA. Activation of human T cells in vivo following treatment of transplant recipients with OKT3. Transplantation. 1990 Oct; 50(4):608-12. PMID: 2145669.
      View in: PubMed
    171. Broelsch CE, Emond JC, Whitington PF, Thistlethwaite JR, Baker AL, Lichtor JL. Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg. 1990 Sep; 212(3):368-75; discussion 375-7. PMID: 2396888.
      View in: PubMed
    172. Thistlethwaite JR, Emond JC, Woodle ES, Vogelbach P, Black DD, Whitington PF, Broelsch CE. Increased utilization of organ donors: transplantation of two recipients from single donor livers. Transplant Proc. 1990 Aug; 22(4):1485-6. PMID: 2389374.
      View in: PubMed
    173. Thistlethwaite JR, Heffron TG, Stevens L, Buckingham M, Stuart JK, Stuart FP. The use of the T-cell flow cytometry crossmatch to evaluate the significance of positive B-cell serologic crossmatches in cadaveric donor renal transplantation. Transplant Proc. 1990 Aug; 22(4):1897-8. PMID: 2389478.
      View in: PubMed
    174. Woodle ES, Thistlethwaite JR, Emond JC, Whitington PF, Black DD, Aran PP, Baker AL, Stuart FP, Broelsch CE. OKT3 therapy for hepatic allograft rejection: comparison of results in adults and children. Transplant Proc. 1990 Aug; 22(4):1765-6. PMID: 2117803.
      View in: PubMed
    175. Emond JC, Whitington PF, Thistlethwaite JR, Cherqui D, Alonso EA, Woodle IS, Vogelbach P, Busse-Henry SM, Zucker AR, Broelsch CE. Transplantation of two patients with one liver. Analysis of a preliminary experience with 'split-liver' grafting. Ann Surg. 1990 Jul; 212(1):14-22. PMID: 2363599.
      View in: PubMed
    176. Singer PA, Siegler M, Lantos JD, Emond JC, Whitington PF, Thistlethwaite JR, Broelsch CE. The ethical assessment of innovative therapies: liver transplantation using living donors. Theor Med. 1990 Jun; 11(2):87-94. PMID: 2203179.
      View in: PubMed
    177. Woodle ES, Thistlethwaite JR, Emond JC, Whitington PF, Vogelbach P, Yousefzadeh DK, Broelsch CE. Successful hepatic transplantation in congenital absence of recipient portal vein. Surgery. 1990 Apr; 107(4):475-9. PMID: 2321142.
      View in: PubMed
    178. Rouch DA, Emond JC, Thistlethwaite JR, Mayes JT, Broelsch CE. Choledochocholedochostomy without a T tube or internal stent in transplantation of the liver. Surg Gynecol Obstet. 1990 Mar; 170(3):239-44. PMID: 2406979.
      View in: PubMed
    179. Emond JC, Mayes JT, Rouch DA, Thistlethwaite JR, Broelsch CE. Experience with radical resection in the management of proximal bile duct cancer. HPB Surg. 1989 Nov; 1(4):297-305; discussion 305-7. PMID: 2487069.
      View in: PubMed
    180. Thistlethwaite JR, Heffron TG, Stuart JK, Buckingham M, Stuart FP. Selective OKT3 induction therapy in adult cadaveric-donor renal transplant recipients. Am J Kidney Dis. 1989 Nov; 14(5 Suppl 2):28-34. PMID: 2510508.
      View in: PubMed
    181. Emond JC, Whitington PF, Thistlethwaite JR, Alonso EM, Broelsch CE. Reduced-size orthotopic liver transplantation: use in the management of children with chronic liver disease. Hepatology. 1989 Nov; 10(5):867-72. PMID: 2807168.
      View in: PubMed
    182. Sennett CA, Messersmith RN, Yousefzadeh DK, Thistlethwaite JR. Percapsular and percutaneous embolization of renal transplant pseudoaneurysm and AV fistula: case report. Cardiovasc Intervent Radiol. 1989 Sep-Oct; 12(5):270-3. PMID: 2514988.
      View in: PubMed
    183. Singer PA, Siegler M, Whitington PF, Lantos JD, Emond JC, Thistlethwaite JR, Broelsch CE. Ethics of liver transplantation with living donors. N Engl J Med. 1989 Aug 31; 321(9):620-2. PMID: 2668769.
      View in: PubMed
    184. Ellis JE, Lichtor JL, Feinstein SB, Chung MR, Polk SL, Broelsch C, Emond J, Thistlethwaite JR, Roizen MF. Right heart dysfunction, pulmonary embolism, and paradoxical embolization during liver transplantation. A transesophageal two-dimensional echocardiographic study. Anesth Analg. 1989 Jun; 68(6):777-82. PMID: 2660629.
      View in: PubMed
    185. Thistlethwaite JR, Woodle ES, Mayes JT, Stuart JK, Heffron TG, Spargo BH, Stuart FP. Aggressive needle biopsy protocol prevents loss of renal allografts to undetected rejection during early posttransplant dysfunction. Transplant Proc. 1989 Feb; 21(1 Pt 2):1890-2. PMID: 2652614.
      View in: PubMed
    186. Lloyd DM, Weiser MR, Kang RH, Buckingham M, Stuart FP, Thistlethwaite JR. Does depletion of donor dendritic cells in an organ allograft lead to prolongation of graft survival on transplantation? Transplant Proc. 1989 Feb; 21(1 Pt 1):482-3. PMID: 2495615.
      View in: PubMed
    187. Woodle ES, Heffron TG, Stuart JK, Thistlethwaite JR, Stuart FP. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function. Transplant Proc. 1989 Feb; 21(1 Pt 2):1641-2. PMID: 2652536.
      View in: PubMed
    188. Perdrizet GA, Heffron TG, Buckingham FC, Salciunas PJ, Gaber AO, Stuart FP, Thistlethwaite JR. Stress conditioning: a novel approach to organ preservation. Curr Surg. 1989 Jan-Feb; 46(1):23-6. PMID: 2656107.
      View in: PubMed
    189. Broelsch E, Vogelbach P, Emond JC, Thistlethwaite JR, Woodle SA, Baker AL, Whitington PF. [Shunt surgery with reference to indications for liver transplantation]. Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir. 1989; 293-9. PMID: 2577559.
      View in: PubMed
    190. Lloyd DM, Cotler SJ, Letai AG, Stuart FP, Thistlethwaite JR. Pancreas-graft immunogenicity and pretreatment with anti-class II monoclonal antibodies. Diabetes. 1989 Jan; 38 Suppl 1:104-8. PMID: 2642828.
      View in: PubMed
    191. Rouch DA, Thistlethwaite JR, Lichtor L, Emond JC, Broelsch CE. Effect of massive transfusion during liver transplantation on rejection and infection. Transplant Proc. 1988 Dec; 20(6):1135-7. PMID: 3059596.
      View in: PubMed
    192. Gaber AO, Thistlethwaite JR, Buckingham FC, Lloyd DM, Ramsy O, Stuart FP. Intermediate normothermic hemoperfusion of rat kidneys: functional aspects and a study into the effect of free radical scavengers. Transplant Proc. 1988 Oct; 20(5):896-8. PMID: 3188194.
      View in: PubMed
    193. Gaber AO, Thistlethwaite JR, Busse-Henry S, Aboushloe M, Emond J, Rouch D, Broelsch CE. Improved results of preservation of hepatic grafts preflushed with albumin and prostaglandins. Transplant Proc. 1988 Oct; 20(5):992-3. PMID: 3055550.
      View in: PubMed
    194. Broelsch CE, Emond JC, Thistlethwaite JR, Whitington PF, Zucker AR, Baker AL, Aran PF, Rouch DA, Lichtor JL. Liver transplantation, including the concept of reduced-size liver transplants in children. Ann Surg. 1988 Oct; 208(4):410-20. PMID: 3052326.
      View in: PubMed
    195. Thistlethwaite JR, Gaber AO, Stuart FP, Lloyd DW, Emond J, Rouch D, Broelsch CE. Procurement of both liver and whole pancreas/duodenum allografts from a single donor without the use of interposition vascular grafts on transplantation. Transplant Proc. 1988 Oct; 20(5):833-4. PMID: 3055509.
      View in: PubMed
    196. Lichtor JL, Emond J, Chung MR, Thistlethwaite JR, Broelsch CE. Pediatric orthotopic liver transplantation: multifactorial predictions of blood loss. Anesthesiology. 1988 Apr; 68(4):607-11. PMID: 3281513.
      View in: PubMed
    197. Broelsch CE, Emond JC, Thistlethwaite JR, Rouch DA, Whitington PF, Lichtor JL. Liver transplantation with reduced-size donor organs. Transplantation. 1988 Mar; 45(3):519-24. PMID: 3279573.
      View in: PubMed
    198. Thistlethwaite JR, Stuart JK, Mayes JT, Gaber AO, Stuart FP. Use of a brief steroid trial before initiating OKT3 therapy for renal allograft rejection. Am J Kidney Dis. 1988 Feb; 11(2):94-8. PMID: 3277413.
      View in: PubMed
    199. Mayes JT, Thistlethwaite JR, Stuart JK, Buckingham MR, Stuart FP. Reexposure to OKT3 in renal allograft recipients. Transplantation. 1988 Feb; 45(2):349-53. PMID: 3278428.
      View in: PubMed
    200. Fox AS, Tolpin MD, Baker AL, Broelsch CE, Whittington PF, Jackson T, Thistlethwaite JR, Stuart FP. Seropositivity in liver transplant recipients as a predictor of cytomegalovirus disease. J Infect Dis. 1988 Feb; 157(2):383-5. PMID: 2826617.
      View in: PubMed
    201. Thistlethwaite JR, Stuart JK, Mayes JT, Gaber AO, Woodle S, Buckingham MR, Stuart FP. Complications and monitoring of OKT3 therapy. Am J Kidney Dis. 1988 Feb; 11(2):112-9. PMID: 3277401.
      View in: PubMed
    202. Doria M, Lloyd D, Thistlethwaite JR, Franklin WA. Immunohistochemical detection of antibody in tissue sections of non-perfused and ex vivo-perfused organs using a tetrazolium alkaline phosphatase substrate. Histochemistry. 1988; 89(5):443-6. PMID: 3049470.
      View in: PubMed
    203. Gaber AO, Thistlethwaite JR, Haag BW, Stuart JK, Mayes JT, Lloyd DM, Fellner S, Stuart FP. Potent immunosuppression overcomes immunologic high-risk factors in recipients of cadaveric renal allografts. Am Surg. 1987 Jul; 53(7):407-9. PMID: 3300451.
      View in: PubMed
    204. Broelsch CE, Then K, Thistlethwaite JR, Emond JC. [Heterotopic or orthotopic liver replacement with liver segments?]. Z Gastroenterol Verh. 1987 Apr; 22:66-72. PMID: 2442912.
      View in: PubMed
    205. Gaber AO, Yang HC, Haag BW, Buckingham FC, Lloyd DM, Thistlethwaite JR, Stuart FP. Intermediate normothermic hemoperfusion doubles safe cold preservation of rat kidneys. Transplant Proc. 1987 Feb; 19(1 Pt 2):1369-71. PMID: 3274334.
      View in: PubMed
    206. Gaber AO, Thistlethwaite JR, Haag BW, Stuart J, Mayes J, Fellner S, Stuart FP. Potent immunosuppression overcomes retransplantation, presensitization, and historical positive crossmatch as transplant risk factors. Transplant Proc. 1987 Feb; 19(1 Pt 3):1915-6. PMID: 3274451.
      View in: PubMed
    207. Thistlethwaite JR, Gaber AO, Haag BW, Aronson AJ, Broelsch CE, Stuart JK, Stuart FP. OKT3 treatment of steroid-resistant renal allograft rejection. Transplantation. 1987 Feb; 43(2):176-84. PMID: 3544373.
      View in: PubMed
    208. Lloyd DM, Franklin W, Buckingham F, Buckingham M, Rizner JS, Stuart FP, Thistlethwaite JR. Ex vivo perfusion of the intact rat pancreas with anti-class II monoclonal antibody: labeling of dendritic cells. Transplant Proc. 1987 Feb; 19(1 Pt 1):620-3. PMID: 3547832.
      View in: PubMed
    209. Thistlethwaite JR, Buckingham M, Stuart JK, Gaber AO, Mayes JT, Stuart FP. T cell immunofluorescence flow cytometry cross-match results in cadaver donor renal transplantation. Transplant Proc. 1987 Feb; 19(1 Pt 1):722-4. PMID: 3079164.
      View in: PubMed
    210. Thistlethwaite JR, Haag BW, Gaber AO, Stuart JK, Aronson AJ, Mayes JT, Lloyd DM, Stuart FP. The use of OKT3 to treat steroid-resistant renal allograft rejection in patients receiving cyclosporine. Transplant Proc. 1987 Feb; 19(1 Pt 3):1901-4. PMID: 3103294.
      View in: PubMed
    211. Stuart FP, Stuart JK, Thistlethwaite JR, Gaber AO, Mayes J. An immunosuppressive protocol compatible with the United States kidney transplant diagnosis related grouping. Transplant Proc. 1987 Feb; 19(1 Pt 3):1959-60. PMID: 3152656.
      View in: PubMed
    212. Thistlethwaite JR, Haag BW, Jones KW, Stuart JK, Stuart FP. Elective conversion from cyclosporine to azathioprine in recipients with stable renal function 6 months after kidney transplantation. Hum Immunol. 1985 Nov; 14(3):314-23. PMID: 3902749.
      View in: PubMed
    213. Thistlethwaite JR, Cosimi AB, Delmonico FL, Rubin RH, Talkoff-Rubin N, Nelson PW, Fang L, Russell PS. Evolving use of OKT3 monoclonal antibody for treatment of renal allograft rejection. Transplantation. 1984 Dec; 38(6):695-701. PMID: 6390834.
      View in: PubMed
    214. Pescovitz MD, Thistlethwaite JR, Auchincloss H, Ildstad ST, Sharp TG, Terrill R, Sachs DH. Effect of class II antigen matching on renal allograft survival in miniature swine. J Exp Med. 1984 Nov 01; 160(5):1495-508. PMID: 6387036.
      View in: PubMed
    215. Thistlethwaite JR, Auchincloss H, Pescovitz MD, Sachs DH. Immunologic characterization of MHC recombinant swine: role of class I and II antigens in in vitro immune responses. J Immunogenet. 1984 Feb; 11(1):9-19. PMID: 6231343.
      View in: PubMed
    216. Thistlethwaite JR, Pennington LR, Lunney JK, Sachs DH. Immunologic characterization of MHC recombinant swine. Production of SLA class specific antisera and detection of Ia antigens on both B and non-B PBL. Transplantation. 1983 Apr; 35(4):394-400. PMID: 6404028.
      View in: PubMed
    217. Pennington LR, Flye MW, Kirkman RL, Thistlethwaite JR, Williams GM, Sachs DH. Transplantation in miniature swine. X. Evidence for non-SLA-linked immune response gene(s) controlling rejection of SLA-matched kidney allografts. Transplantation. 1981 Oct; 32(4):315-20. PMID: 6800077.
      View in: PubMed
    218. THOMPSON JF, MAZELLA SF, THISTLETHWAITE JR. ANEURYSM OF THE CELIAC ARTERY: CASE REPORT OF SUCCESSFUL MANAGEMENT. Ann Surg. 1965 Jan; 161:83-5. PMID: 14252638.
      View in: PubMed
    219. THISTLETHWAITE JR, SMITH DF. EVALUATION OF SPHINCTEROTOMY FOR THE TREATMENT OF CHRONIC RECURRENT PANCREATITIS. Ann Surg. 1963 Aug; 158:226-32. PMID: 14047545.
      View in: PubMed
    220. McCUNE WS, THISTLETHWAITE JR. Fistula cancer. Ann Surg. 1959 Jun; 149(6):815-20; discussion 821. PMID: 13650467.
      View in: PubMed
    221. ALBERT SN, SPENCER WA, SHIBUYA J, COAKLEY CS, THISTLETHWAITE JR. Observations on fluctuations in blood volume as determined with radioactive isotopes. Anesth Analg. 1957 Sep-Oct; 36(5):54-60. PMID: 13470379.
      View in: PubMed
    222. THISTLETHWAITE JR, SPENCER WA, ALBERT SN. Blood volume fluctuations determined by radioisotopes of chromium and radioactive iodinated serum albumin. Surg Gynecol Obstet. 1957 Jul; 105(1):34-8. PMID: 13442903.
      View in: PubMed
    223. THISTLETHWAITE JR, HILL RP. Serum amylase levels in experimental pancreatitis. Surgery. 1952 Apr; 31(4):495-501. PMID: 14922095.
      View in: PubMed
    224. McCUNE WS, THISTLETHWAITE JR, KESHISHIAN JM, BLADES B. The nutrition of blood vessel grafts. An India ink injection study of their vascularization. Surg Gynecol Obstet. 1952 Mar; 94(3):311-6. PMID: 14901269.
      View in: PubMed
    225. BEATTIE EJ, THISTLETHWAITE JR, BLADES B, WOOD O. Experimental studies with intra-arterial transfusion; over transfusion of the normal dog. Surgery. 1952 Mar; 31(3):411-20. PMID: 14913456.
      View in: PubMed
    226. THISTLETHWAITE JR. The effect of banthine, vagotomy, and subtotal gastrectomy upon pancreatic secretion. Surg Gynecol Obstet. 1951 Nov; 93(5):616-20. PMID: 14893066.
      View in: PubMed
    227. GERWIG WH, THISTLETHWAITE JR. Cholecystitis and cholelithiasis in young women following pregnancy. Surgery. 1950 Dec; 28(6):983-96. PMID: 14787834.
      View in: PubMed
    Thistlethwaite's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _